Karabelas Argeris N (CIK 0001191229)

Latest company ownership

Shares held
123,715
Last filed at
Jun 28, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2016Q3 2025Q4
RGNX - REGENXBIO Inc.
Role: Director
Shares held
39,815
Last filed at
Jun 3, 2025
Confidence Score
49.8
2025Q4
Confidence Score History
2024Q3 2025Q4
Shares held
15,000
Last filed at
Jun 17, 2011
Confidence Score
50.0
2025Q4
Confidence Score History
2009Q4 2025Q4
Shares held
12,000
Last filed at
Jun 26, 2015
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Oct 1, 2024 Oct 2, 2024 REGENXBIO Inc. Director Sell 10.0 -10,000 -46.98% ✓ $101.1K
Sep 3, 2024 Sep 4, 2024 REGENXBIO Inc. Director Sell 10.0 -10,000 -46.98% ✓ $115.6K
Aug 1, 2024 Aug 5, 2024 REGENXBIO Inc. Director Sell 10.0 -10,100 -47.23% ✓ $136.5K
Jul 29, 2024 Jul 30, 2024 REGENXBIO Inc. Director Sell 10.0 -11,000 -49.36% ✓ $165.5K
Jul 1, 2024 Jul 3, 2024 REGENXBIO Inc. Director Sell 10.0 -10,000 -46.98% ✓ $112.7K
Aug 11, 2016 Aug 12, 2016 Bausch Health Companies Inc. Director Buy 95.0 +4,000 23.91% ✗ $98.6K
Feb 23, 2015 Feb 25, 2015 ROCKET PHARMACEUTICALS, INC. Director Buy 100.0 +603,832 36.09% ✗ $3.6M
Mar 12, 2010 Mar 15, 2010 Vanda Pharmaceuticals Inc. Director Sell 17.5 -200,000 -100.00% ✗ $2.4M
Dec 14, 2009 Dec 16, 2009 Vanda Pharmaceuticals Inc. Director Sell 17.5 -228,924 -53.37% ✗ $2.5M
Dec 8, 2009 Dec 10, 2009 Vanda Pharmaceuticals Inc. Director Sell 17.5 -133,576 -23.75% ✗ $1.5M
Dec 4, 2009 Dec 8, 2009 Vanda Pharmaceuticals Inc. Director Sell 17.5 -200,000 -26.23% ✗ $2.3M
Oct 13, 2009 Oct 15, 2009 Vanda Pharmaceuticals Inc. Director Sell 17.5 -237,500 -23.75% ✗ $3M